Why OPKO Health, Inc.’s (OPK) Stock Is Down 5.45%
As of Wednesday, July 29, OPKO Health, Inc.’s OPK share price has dipped by 5.45%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.
Commentary & Analysis
Why OPKO Health, Inc.’s (OPK) Stock Is Down 13.39%
As of Wednesday, July 29, OPKO Health, Inc.’s OPK share price has dipped by 13.39%, which has investors questioning if this is right time to buy.Jenna Brashear
Why OPKO Health, Inc.’s (OPK) Stock Is Up 18.95%
As of Tuesday, July 28, OPKO Health, Inc.’s OPK share price has surged by 18.95%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why OPKO Health, Inc.’s (OPK) Stock Is Up 33.88%
As of Tuesday, July 28, OPKO Health, Inc.’s OPK share price has surged by 33.88%, which has investors questioning if this is right time to sell.Tudor Pop
Why OPKO Health, Inc.’s (OPK) Stock Is Down 6.64%
As of Wednesday, April 29, OPKO Health, Inc.’s OPK share price has dipped by 6.64%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | OPK | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $985.2 | $1,742.7 | 45% |
|
| Shares Out (Mil) | 755.3 | 76.7 | 92% |
|
| Institutional Ownership | 36.9% | 89.7% | 16% |
|
| Float (Mil) | 323.7 | 49.4 | 81% |
|
| Beta | 1.48 | 0.82 | 82% |
|
| Avg Daily Volume (000s) | 6,820 | 521 | 94% |
|
| Price Change (52-week) |
(1.5%) | 78.7% | 44% |
|
| Growth | OPK | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (15.8%) | 11.0% | 3% |
|
| Net Income (5yr) | (56.5%) | (0.7%) | 6% |
|
| EPS (5yr) | (52.5%) | 3.1% | 3 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (32.0%) | (18.0%) | 17% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 1 | 2 | |
| Current EPS | ($0.070) | ($0.220) | ($0.275) | |
| Month Ago EPS | ($0.110) | ($0.380) | ($0.320) | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | ($0.110) | ($0.380) | ($0.320) | |
| Year/Year Chg | 536.4% | (26.7%) | (65.0%) | |
| Financials | OPK | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $588 | $1,456 | 43% |
|
| Net Income (TTM) (Mil) | ($73) | $12 | 13% |
|
| EPS (TTM) | ($0.094) | $0.300 | 36% |
|
| Operating Cash Flow (TTM) (Mil) | ($123) | $138 | 5% |
|
| Net Cash Flow (TTM) (Mil) | $29 | $8 | 66% |
|
| Long-Term Debt (Q1) (Mil) | $375 | $316 | 56% |
|
| Enterprise Value (Q1) (Mil) | $1,023 | $2,170 | 41% |
|
| Valuation | OPK | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.83 | 2.85 | 17% |
|
| P/E | na | 26.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | OPK | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 19.6% | 27.8% | 20% |
|
| Net Margin | (12.4%) | 1.1% | 20% |
|
| ROA | (3.8%) | 1.8% | 31% |
|
| ROE | (5.9%) | 7.1% | 30% |
|
| Liabilities to Assets | 35.3% | 59.9% | 26% |
|
| F-Score | 3 | 5 | 19% |
|
OPKO Health, Inc. did not pass any screens on 7/31/2026.
